Literature DB >> 8964908

Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism.

V K Singh1.   

Abstract

Immune factors such as autoimmunity have been implicated in the genesis of autism, a neurodevelopmental disorder. Since autoimmune response involves immune activation, the plasma levels of interferon-alpha (IFN-alpha), interferon-gamma (IFN-gamma), interleukin-12 (IL-12), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and soluble intercellular adhesion molecule-1 (sICAM-1) were measured in autistic patients and age-matched normal controls. The levels of IL-12 and IFN-gamma were significantly (P < or = 0.05) higher in patients as compared to controls. However, IFN-alpha, IL-6, TNF-alpha, and sICAM-1 levels did not significantly differ between the two groups. Because macrophage-derived IL-12 is known to selectively induce IFN-gamma in T helper type-1 (Th-1) cells, it is suggested that IL-12 and IFN-gamma increases may indicate antigenic stimulation of Th-1 cells pathogenetically linked to autoimmunity in autism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964908     DOI: 10.1016/0165-5728(96)00014-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  51 in total

1.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

Review 2.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

3.  Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.

Authors:  Paul Ashwood; Joseph Schauer; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2009-02-10       Impact factor: 3.478

4.  Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation.

Authors:  Destanie R Rose; Milo Careaga; Judy Van de Water; Kim McAllister; Melissa D Bauman; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2016-11-19       Impact factor: 7.217

Review 5.  Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?

Authors:  Milo Careaga; Jared Schwartzer; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2014-06-14       Impact factor: 7.217

Review 6.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

7.  Immune Endophenotypes in Children With Autism Spectrum Disorder.

Authors:  Milo Careaga; Sally Rogers; Robin L Hansen; David G Amaral; Judy Van de Water; Paul Ashwood
Journal:  Biol Psychiatry       Date:  2015-09-11       Impact factor: 13.382

8.  Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Authors:  Paul Ashwood; Amanda Enstrom; Paula Krakowiak; Irva Hertz-Picciotto; Robin L Hansen; Lisa A Croen; Sally Ozonoff; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

9.  Altered gene expression and function of peripheral blood natural killer cells in children with autism.

Authors:  Amanda M Enstrom; Lisa Lit; Charity E Onore; Jeff P Gregg; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto; Judy A Van de Water; Frank R Sharp; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2008-08-14       Impact factor: 7.217

10.  Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report.

Authors:  Heather E Ross; Ying Guo; Karlene Coleman; Opal Ousley; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2013-01-24       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.